Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex.
Ontology highlight
ABSTRACT: Alzheimer's Disease (AD) is the leading form of dementia worldwide. Currently, the pathological mechanisms underlying AD are not well understood. Although the glutamatergic system is extensively implicated in its pathophysiology, there is a gap in knowledge regarding the expression of glutamate receptors in the AD brain. This study aimed to characterize the expression of specific glutamate receptor subunits in post-mortem human brain tissue using immunohistochemistry and confocal microscopy. Free-floating immunohistochemistry and confocal laser scanning microscopy were used to quantify the density of glutamate receptor subunits GluA2, GluN1, and GluN2A in specific cell layers of the hippocampal sub-regions, subiculum, entorhinal cortex, and superior temporal gyrus. Quantification of GluA2
SUBMITTER: Yeung JHY
PROVIDER: S-EPMC8549033 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA